Clinical Trials

235 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT06112613 2026-04-03

Mobile Health for Adherence in Breast Cancer Patients

410 enrolled

Breast Neoplasms

NCT03723928 2026-04-02

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

739 enrolled

Anatomic Stage IV Breast Cancer AJCC v8

NCT05076266 2026-04-02

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

Terminated

14 enrolled 10 charts

Phase NA Active not recruiting

Breast Neoplasms

NCT05568472 2026-04-02

ASPEN

565 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT02445391 2026-04-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

415 enrolled 15 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00003140 2026-03-27

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Phase 3 Completed

5,187 enrolled

Breast Neoplasms

NCT00066443 2026-03-27

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Phase 1/2 Completed

93 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03568422 2026-03-27

CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

37 enrolled 14 charts

Breast Neoplasms

NCT05601440 2026-03-27

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Phase 2 Recruiting

484 enrolled

Breast Neoplasms

NCT03233191 2026-03-23

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

108,508 enrolled

Breast Screening

NCT04266249 2026-03-23

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

2,175 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT04316117 2026-03-23

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

138 enrolled

Breast Neoplasms

NCT04001829 2026-03-13

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

249 enrolled 14 charts

Anatomic Stage I Breast Cancer AJCC v8

NCT01349322 2026-03-05

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

2,354 enrolled 29 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05896566 2026-02-24

PREcoopERA

Phase 2 Completed

231 enrolled

Breast Neoplasms

NCT07425002 2026-02-20

PRISM

1,600 enrolled

Breast Neoplasms

NCT04176848 2026-02-18

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

15 enrolled 7 charts

Breast Neoplasms

NCT01674140 2026-02-10

e3

1,939 enrolled 15 charts

Phase NA Active not recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT02308085 2026-02-09

POSITIVE

518 enrolled

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

Phase 3 Completed

3,066 enrolled 15 charts

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

Phase 3 Completed

2,672 enrolled 14 charts

Breast Neoplasms

NCT07380971 2026-02-02

Developing a Comprehensive Exercise Service for Breast Cancer Process

Recruiting

200 enrolled

Breast Neoplasms, Motor Activity

NCT03624543 2026-01-30

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

51 enrolled

Breast Neoplasms

NCT06995443 2026-01-30

REGAIN

200 enrolled

Breast Neoplasms, Neoplasms, Cognitive Dysfunction

NCT01840293 2025-12-19

Breast Cancer Proteomics and Molecular Heterogeneity

Recruiting

1,780 enrolled

Breast Neoplasms

NCT02050750 2025-12-19

TAILORx Tissue Bank

Active not recruiting

600 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT02352883 2025-12-19

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

368 enrolled

Carcinoma, Intraductal, Noninfiltrating

NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Phase 3 Recruiting

2,400 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT07084558 2025-10-28

TEODOR

350 enrolled

Breast Neoplasms

NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Phase 3 Recruiting

491 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT03283384 2025-09-19

NEOLBC

100 enrolled

Breast Neoplasms

NCT03425838 2025-09-19

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

1,050 enrolled

Breast Neoplasm Female

NCT03820063 2025-09-19

TRAIN-3

462 enrolled

Breast Neoplasms

NCT04489173 2025-09-19

TIBET

52 enrolled

Breast Neoplasms

NCT05392608 2025-09-17

SEQUEL-Breast

130 enrolled

Breast Neoplasms, Genetic Diseases, Inborn

NCT01766297 2025-09-09

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Phase 2 Recruiting

132 enrolled

Breast Neoplasms

NCT05856773 2025-09-09

COMPRO

Phase 3 Recruiting

276 enrolled

Breast Neoplasms

NCT01758445 2025-09-04

Proton Radiation for Stage II/III Breast Cancer

220 enrolled